跳至主要内容
临床试验/NCT01460966
NCT01460966已完成不适用

Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)

Yokohama City University Medical Center2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
2
主要终点
Incidence of no-reflow/slow-flow phenomenon after percutaneous coronary intervention (PCI)

研究概览

简要总结

Attenuated plaque ≥ 5mm by intravascular ultrasound(IVUS) was reported to be high risk for distal embolism in Acute coronary syndrome(ACS). The purpose of this study is to assess the effect of thrombus aspiration catheter and distal protection device (filter wire; Filtrap™) in the aforementioned subgroup of patients at high risk for distal embolism.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who were diagnosed as ACS and meet the following criteria.
  • Patients with acute myocardial infarction or unstable angina within 2 months from onset.
  • Patients who have severe coronary stenosis which require PCI and in whom attenuated plaque ≥ 5mm (longitudinally) by IVUS before PCI is observed prior to balloon dilatation and stent deployment.

排除标准

  • Patients who need balloon expansion (including small diameter balloon) for IVUS catheter crossing.
  • Patients who were resuscitated after dead on arrival
  • Graft lesion or in-stent restenosis lesion
  • Patients on dialysis or renal failure (Cr>1.5mg/dl).
  • Left main trunk lesion
  • Target vessel size is <2.5mm or >5mm
  • Ineligible for PCI
  • Lactating and (possibly) pregnant woman or having possibility of pregnant
  • Patients who are considered ineligible by the attending physician

结局指标

主要结局

Incidence of no-reflow/slow-flow phenomenon after percutaneous coronary intervention (PCI)

时间窗: a day

次要结局

  • Myocardial blush grade(8-12months)
  • Incidence of stent thrombosis(8-12months)
  • Plaque protrusion by IVUS inside the stent(8-12months)
  • Improvement of Thrombolysis in Myocardial Infarction (TIMI) flow grade compared with baseline(8-12months)
  • Rise in CK-MB and troponin I or T the next morning after PCI (Peak of CK too in case of ST-segment elevation myocardial infarction )(a day)
  • Incidence of clinical events including mortality, major adverse cardiac events, and Hospitalization for heart failure(10months)
  • Corrected TIMI frame count(8-12months)
  • TIMI flow grade(8-12months)
  • Incidence of any revascularization(8-12months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kiyoshi Hibi

Yokohama City University Medical Center

Yokohama City University Medical Center

研究点 (2)

Loading locations...

相似试验